Thresholds, security and access: how Europe is reshaping the framework for the therapeutic and industrial plant sector
In Europe, the sector of plants used for therapeutic and industrial purposes is entering a phase of accelerated clarification
In Europe, the sector of plants used for therapeutic and industrial purposes is entering a phase of accelerated clarification
Cannabis extracts are playing an increasingly important role in clinical discussions, whether in formulations rich in…
For a long time, hemp-based solutions were presented to businesses from the perspective of comfort, of…
Choosing a hemp resin may seem simple at first glance, but in practice, the real difference between…
When comparing greenhouse cultivation and indoor cultivation, the question is not limited to…
In recent years, hemp extracts have become a prominent topic in conversations about sleep. Oils of…
By 2026, the European landscape of plant extracts will enter a much more clearly structured phase. Between…
In France, the management of plant-based products is entering a new phase. Between increased roadside checks, pressure…
In 2026, the EFSA's provisional opinion on CBD clearly reshuffles the cards for the entire hemp industry…
The European market for modern plant extracts is entering a decisive phase. Between botanical innovations, new ingredients derived from…